Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-055052

Chief Financial Officer acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lucera Erick · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-12 Grant or award : show line 1 in the form +65,000 131,100 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-12 Grant or award : show line 2 in the form Stock Option (Right to Buy) +105,000 105,000 D
Loading xslF345X05/ownership.xml…